β-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFκB gene expression network in osteoblasts

Bone

Volumn 45, Issue 4, 2009, Pages 716-725

  Bianchi, Estelle N ^a   Ferrari, Serge L ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Arrestin; Bone; Gene expression; Osteoblast; PTH

Indexed keywords

ASPORIN; BETA ARRESTIN 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOGLYCIN; OSTEOMODULIN; PARATHYROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CATABOLISM; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SEQUENCE; GENE TARGETING; HORMONE INHIBITION; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOBLAST; UPREGULATION; WILD TYPE;

ANIMALS; ARRESTINS; CELL DIFFERENTIATION; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MICE; NF-KAPPA B; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARATHYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 68949173918     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.06.020     Document Type: Article

References (47)

1. Lefkowitz R.J.G. Protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273 (1998) 18677-18680
2. Lefkowitz R.J. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 25 (2004) 413-422
3. Bohn L.M., Gainetdinov R.R., Lin F.T., Lefkowitz R.J., and Caron M.G. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408 (2000) 720-723
4. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., et al. Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112 (2003) 566-574
5. Bouxsein M.L., Pierroz D.D., Glatt V., Goddard D.S., Cavat F., Rizzoli R., et al. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J. Bone Miner. Res. 20 (2005) 635-643
6. Ferrari S.L., Pierroz D.D., Glatt V., Goddard D.S., Bianchi E.N., Lin F.T., et al. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-arrestin2. Endocrinology 146 (2005) 1854-1862
7. Pierroz D.D., Rufo A., Bianchi E.N., Glatt V., Capulli M., Rucci N., et al. Beta-arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J. Bone Miner. Res. (2008)
8. Bisello A., Chorev M., Rosenblatt M., Monticelli L., Mierke D.F., and Ferrari S.L. Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J. Biol. Chem. 277 (2002) 38524-38530
9. Ferrari S.L., Behar V., Chorev M., Rosenblatt M., and Bisello A. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J. Biol. Chem. 274 (1999) 29968-29975
10. Mannstadt M., Juppner H., and Gardella T.J. Receptors for PTH and PTHrP: their biological importance and functional properties. Am. J. Physiol. 277 (1999) F665-F675
11. Rey A., Manen D., Rizzoli R., Caverzasio J., and Ferrari S.L. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation. J. Biol. Chem. 281 (2006) 38181-38188
12. Sneddon W.B., and Friedman P.A. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization. Endocrinology 148 (2007) 4073-4079
13. Karaplis A.C., and Goltzman D. PTH and PTHrP effects on the skeleton. Rev. Endocr. Metab. Disord. 1 (2000) 331-341
14. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N. Engl. J. Med. 344 (2001) 1434-1441
15. Lotinun S., Evans G.L., Bronk J.T., Bolander M.E., Wronski T.J., Ritman E.L., et al. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties. J. Bone Miner. Res. 19 (2004) 1165-1171
16. Silverberg S.J., Shane E., de la Cruz L., Dempster D.W., Feldman F., Seldin D., et al. Skeletal disease in primary hyperparathyroidism. J. Bone Miner. Res. 4 (1989) 283-291
17. Qin L., Raggatt L.J., and Partridge N.C. Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol. Metab. 15 (2004) 60-65
18. Goltzman D. Interactions of PTH and PTHrP with the PTH/PTHrP receptor and with downstream signaling pathways: exceptions that provide the rules. J. Bone Miner. Res. 14 (1999) 173-177
19. Iida-Klein A., Zhou H., Lu S.S., Levine L.R., Ducayen-Knowles M., Dempster D.W., et al. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J. Bone Miner. Res. 17 (2002) 808-816
20. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
21. Martin T.J., and Sims N.A. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol. Med. 11 (2005) 76-81
22. Luben R.A., Wong G.L., and Cohn D.V. Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology 99 (1976) 526-534
23. Hubbell E., Liu W.M., and Mei R. Robust estimators for expression analysis. Bioinformatics 18 (2002) 1585-1592
24. Liu W.M., Mei R., Di X., Ryder T.B., Hubbell E., Dee S., et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18 (2002) 1593-1599
25. Brazma A., Parkinson H., Sarkans U., Shojatalab M., Vilo J., Abeygunawardena N., et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31 (2003) 68-71
26. Ishizuya T., Yokose S., Hori M., Noda T., Suda T., Yoshiki S., et al. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J. Clin. Invest. 99 (1997) 2961-2970
27. Li X., Liu H., Qin L., Tamasi J., Bergenstock M., Shapses S., et al. Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J. Biol. Chem. 282 (2007) 33086-33097
28. Onyia J.E., Helvering L.M., Gelbert L., Wei T., Huang S., Chen P., et al. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J. Cell. Biochem. 95 (2005) 403-418
29. Armamento-Villareal R., Ziambaras K., Abbasi-Jarhomi S.H., Dimarogonas A., Halstead L., Fausto A., et al. An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats. J. Bone Miner. Res. 12 (1997) 384-392
30. Hilliker S., Wergedal J.E., Gruber H.E., Bettica P., and Baylink D.J. Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone 19 (1996) 469-477
31. Rixon R.H., Whitfield J.F., Gagnon L., Isaacs R.J., Maclean S., Chakravarthy B., et al. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J. Bone. Miner. Res. 9 (1994) 1179-1189
32. Fu Q., Jilka R.L., Manolagas S.C., and O Brien C.A. Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J. Biol. Chem. 277 (2002) 48868-48875
33. Huening M., Yehia G., Molina C.A., and Christakos S. Evidence for a regulatory role of inducible cAMP early repressor in protein kinase a-mediated enhancement of vitamin D receptor expression and modulation of hormone action. Mol. Endocrinol. 16 (2002) 2052-2064
34. Koh A.J., Beecher C.A., and Rosol T.J. McCauley LK. 3′,5′-cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro. Endocrinology 140 (1999) 3154-3162
35. McCarthy T.L., Centrella M., and Canalis E. Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J. Biol. Chem. 265 (1990) 15353-15356
36. Rey A., Manen D., Rizzoli R., Ferrari S.L., and Caverzasio J. Evidences for a role of p38 MAP kinase in the stimulation of alkaline phosphatase and matrix mineralization induced by parathyroid hormone in osteoblastic cells. Bone 41 (2007) 59-67
37. Doggett T.A., Swarthout J.T., Jefcoat Jr. S.C., Wilhelm D., Dieckmann A., Angel P., et al. Parathyroid hormone inhibits c-Jun N-terminal kinase activity in rat osteoblastic cells by a protein kinase A-dependent pathway. Endocrinology 143 (2002) 1880-1888
38. Swarthout J.T., Doggett T.A., Lemker J.L., and Partridge N.C. Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J. Biol. Chem. 276 (2001) 7586-7592
39. Gesty-Palmer D., Chen M., Reiter E., Ahn S., Nelson C.D., Wang S., et al. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J. Biol. Chem. 281 (2006) 10856-10864
40. Gesty-Palmer D., Spurney R.F., Flannery P.J., and Yuan L. The PTH 1 receptor (PTHR1) stimulates bone formation through a distinct β-arrestin dependent pathway independent of G protein activation. J. Bone Miner. Res. 23 (2008) S64
41. Gao H., Sun Y., Wu Y., Luan B., Wang Y., Qu B., et al. Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell. 14 (2004) 303-317
42. Chen F., Castranova V., Shi X., and Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 45 (1999) 7-17
43. Eghbali-Fatourechi G., Khosla S., Sanyal A., Boyle W.J., Lacey D.L., and Riggs B.L. Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111 (2003) 1221-1230
44. Tasheva E.S., Klocke B., and Conrad G.W. Analysis of transcriptional regulation of the small leucine rich proteoglycans. Mol. Vis. 10 (2004) 758-772
45. Teplyuk N.M., Haupt L.M., Ling L., Dombrowski C., Mun F.K., Nathan S.S., et al. The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts. J. Cell. Biochem. 107 (2009) 144-154
46. Janssens K., ten Dijke P., Janssens S., and Van Hul W. Transforming growth factor-beta1 to the bone. Endocr. Rev. 26 (2005) 743-774
47. Chen W., Kirkbride K.C., How T., Nelson C.D., Mo J., Frederick J.P., et al. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301 (2003) 1394-1397